Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 8
173
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Three Novel Monoterpenoid Glycosides From Fruits Of Eleutherococcus Henryi

, , , , &
Pages 1299-1306 | Received 22 May 2019, Accepted 14 Jul 2019, Published online: 30 Jul 2019

References

  • Bian XB, Wang SJ, Liu JP, Zhao Y, Li HJ, Zhang LX, Li PY. 2019. Hepatoprotective effect of chiisanoside against acetaminophen-induced acute liver injury in mice. Nat Prod Res. 33(18):2704–2707.
  • Chen C, Zhang DF, Zhao Y, Cai EB, Zhu HY, Gao YG. 2019. A new 3,4-seco-lupane triterpenene glycosyl ester from the leaves of Eleutherococcus sessiliflorus. Nat Prod Res. 23:1–4.
  • Calis I, Yürüker A, Rüegger H, Wright AD, Sticher O. 1993. Anatolioside E: a new acyclic monoterpene glycoside from Viburnum orientale. Helv Chim Acta. 76:2563–2569.
  • Chang SW, Kim KH, Lee IK, Choi SU, Lee KR. 2009. Phytochemical constituents of Geranium eriostemon. Nat Prod Sci. 15:151–155.
  • Delectis Florae Reipublicae Popularis Sinicae. Agendae Academiae Sinicae Edita 1978. Flora Reipublicae Popularis Sinicae. Beijing: Science Press.
  • Hunan Food and Drug Administration 2009. Provincial standard for traditional Chinese medicinal materials in Hunan. Changsha: Hunan Science and Technology Press.
  • Han YH, Li Z, Um JY, Liu XQ, Hong SH. 2016. Anti-adipogenic effect of Glycoside St-E2 and Glycoside St-C1 isolated from the leaves of Acanthopanax henryi (Oliv.) Harms in 3T3-L1 cells. Biosci Biotechnol Biochem. 80(12):2391–2400.
  • Kang D-H, Kang O-H, Li Z, Mun S-H, Seo Y-S, Kong R, Tian Z, Liu X, Kwon D-Y. 2016. Anti-inflammatory effects of Ciwujianoside C3, extracted from the leaves of Acanthopanax henryi (Oliv.) Harms, on LPS-stimulated RAW 264.7 cells. Mol Med Rep. 14(4):3749–3758.
  • Liu HY, Kim JW, Liu XQ, Yook CS. 2012. Study on chemical constituents from root barks of Acanthopanax henryi. J TCM Univ Hunan. 32:34–37.
  • Li Z, Kim JH, Liu XQ, Lee KT, Yook CS. 2014b. Anticancer effects in vitro and chemical compositions of extracts of Acanthopanax henryi. J Acupunct Herbs. 1:49–54.
  • Li Z, Li XJ, Kwon OK, Wang X, Zou QP, Liu XQ, Lee HK. 2015. Chemical constituents from leaves of Acanthopanax henryi (II). Nat Prod Sci. 21:196–204.
  • Li Z, Zou QP, Li XJ, Ye HX, Huang WC, Xie X, Liu XQ. 2014a. Study on chemical constituents from the leaves of Acanthopanax henryi (Oliv.) Harms. J TCM Univ Hunan. 34:24–27.
  • Park SH, Nhiem NX, Kiem PV, Choi EM, Kim JA, Kim YH. 2010. A new norlupane triterpene from the leaves of Acanthopanax koreanum increases the differentiation of osteoblastic MC3T3-e1 cells. Arch Pharm Res. 33(1):75–80.
  • Seo YS, Lee SJ, Li Z, Kang OH, Kong R, Kim SA, Zhou T, Song YS, Liu XQ, Kwon DY. 2017. Araliasaponin II isolated from leaves of Acanthopanax henryi (Oliv.) Harms inhibits inflammation by modulating the expression of inflammatory markers in murine macrophages. Mol Med Rep. 16(1):857–864.
  • Titheradge MA. 1998. The enzymatic measurement of nitrate and nitrite. Methods Mol Biol. 100:83–91.
  • Yoshikawa M, Morikawa T, Oominami H, Matsuda H. 2009. Absolute stereostructures of olibanumols A, B, C, H, I, and J from olibanum, gum-resin of Boswellia carterii, and inhibitors of nitric oxide production in lipopolysaccharide-activated mouse peritoneal macrophages. Chem Pharm Bull. 57(9):957–964.
  • Zhang HC, Jia ZJ. 1993. Study on chemical constituents of Acanthopanax henryi (Oliv.) Harms. J Lanzhou Univ (Nat Sci). 29:76–79.
  • Zhang XD, Liu XQ, Kim YH, Whang WK. 2014. Chemical constituents and their acetyl cholinesterase inhibitory and antioxidant activities from leaves of Acanthopanax henryi: potential complementary source against Alzheimer's disease. Arch Pharm Res. 37(5):606–616.
  • Zhou T, Li Z, Kang OH, Mun SH, Seo YS, Kong R, Shin DW, Liu XQ, Kwon DY. 2017. Antimicrobial activity and synergism of ursolic acid 3-O-α-L-arabinopyranoside with oxacillin against methicillin-resistant Staphylococcus aureus. Int J Mol Med. 40(4):1285–1293.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.